NCT04315896 Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) Status COMPLETED Phase PHASE3
NCT04315298 Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 Status COMPLETED Phase PHASE2/PHASE3
NCT04313946 Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays Status UNKNOWN Phase N/A
NCT04313127 Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults Status COMPLETED Phase PHASE1
NCT04313023 The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 Status COMPLETED Phase PHASE2
NCT04312997 The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection Status COMPLETED Phase PHASE2
NCT04311398 Development and Verification of a New Coronavirus Multiplex Nucleic Acid Detection System Status UNKNOWN Phase N/A
NCT04310865 Yinhu Qingwen Granula for the Treatment of Severe CoVID-19 Status SUSPENDED Phase PHASE2/PHASE3
NCT04310228 Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 Status UNKNOWN Phase NA
NCT04307693 Comparison of Lopinavir/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19) Status TERMINATED Phase PHASE2
NCT04306705 Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19 Status UNKNOWN Phase N/A
NCT04304053 Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention Status COMPLETED Phase PHASE3
NCT04302519 Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells Status UNKNOWN Phase EARLY_PHASE1
NCT04298814 Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia Status WITHDRAWN Phase N/A
NCT04295551 Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe) Status UNKNOWN Phase NA